ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO970

Race-Neutral 2021 CKD-EPI Creatinine eGFR and Iohexol-Measured GFR in Living Kidney Donor Candidates

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • Dabbas, Walaa, University of Illinois Chicago, Chicago, Illinois, United States
  • Naik, Ruchi Harshadrai, University of Illinois Chicago, Chicago, Illinois, United States
  • Gallon, Lorenzo G., University of Illinois Chicago, Chicago, Illinois, United States
  • Tang, Ignatius Yun-Sang, University of Illinois Chicago, Chicago, Illinois, United States
Background

The race neutral 2021 CKD EPI creatinine (Cr) eGFR was approved by the OPTN to calculate kidney function for transplant candidates on the national waitlist to address disparities in kidney transplantation. The 2021 CKD EPI Cr equation estimates a lower GFR for Black patients and a higher GFR for non -Black patients for the same creatinine value. Hence the 2021 CKD EPI Cr eGFR may not provide an accurate estimate of kidney function of potential living kidney donors

Methods

single center retrospective review of charts of potential kidney donors who had measured GFR by Iohexol clearance between January 1, 2021 and December 31, 2023. Data collected include demographics, eGFR calculated by race neutral 2021 CKD EPI Cr equation and Iohexol GFR test. Subjects were divided into 2 groups, Black and Non Black.

Results

Iohexol clearance was done in 333 kidney donor candidates, 62.7% were female and 23.7% were black. The average BMI was 30.4 kg/ m 2 . There was a positive correlation between 2021 CKD EPI Cr eGFR and Iohexol GFR in both groups. Black donor candidates had lower eGFR calculated by 2021 CKD EPI Cr compared to non black, p=0.002. See table. There was no significant difference between Iohexol clearance between the 2 groups. The race neutral 2021 CKD EPI Cr eGFR overestimated GFR in non black compared to black individuals, p=0.02.

Conclusion

2021 CKD EPI Cr eGFR correlated with the Iohexol GFR in black kidney donor candidates, however it overestimated GFR in non black kidney donors.